ASPIRE 2023: Sharing best practice and enriching excellence

Managing asthma in Australia, what should we aspire to?

Recorded on: 20 November 2023

What is the new normal in the Australian asthma landscape? What are the outcomes we shouldn’t accept? When should we consider a biological treatment, which one do we choose, what is best for our patient and why? What does asthma remission look like? When should we switch biologics?

In the four on-demand videos below, A/Prof. John Blakey, Prof. Peter Wark and respiratory nurses Brooke Kyle, John Harrington (Chair), Eddie Weber and Adriana Avram review the Australian asthma landscape and explore what we should ASPIRE to for patients with severe asthma in 2023 and beyond. View now to find out more from our experts.

Duration: 1 hr 22 min

To select a specific chapter, click on the videos below

Current landscape of asthma in Australia: The new normal that we shouldn’t accept

Presenter: CNC John Harrington
Duration: 28 min

Success in asthma therapies: Remission in asthma; definitions, directions and disagreements

Presenter: A/Prof. John Blakey and CNC Brooke Kyle
Duration: 23 min

Which biologic and why? When to switch to another one?

Presenter: Prof. Peter Wark
Duration: 20 min

Q&A with panel discussion

Facilitated by John Harrington with expert speakers and ASPIRE steering committee
Duration: 12 min

Download presentation slides Download full reference list Back to ADVENT home page View ADVENT knowledge centre

Similar resources

PBS Information:

Authority Required. Refer to PBS schedule for full authority information.

Please review full Product Information before prescribing. Full Product Information is available here or by calling 1800 818 806.

▼This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems.

MAT-AU-2302337 - 1.0 - 09/2024